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The cellular prion protein PrPC is highly expressed in neurons, but also present in
non-neuronal tissues, including the testicles and spermatozoa. Most immune cells and
their bone marrow precursors also express PrPC. Clearly, this protein operates in highly
diverse cellular contexts. Investigations into putative stress-protective roles for PrPC
have resulted in an array of functions, such as inhibition of apoptosis, stimulation
of anti-oxidant enzymes, scavenging roles, and a role in nuclear DNA repair. We
have studied stress resilience of spermatozoa and peripheral blood mononuclear cells
(PBMCs) derived from non-transgenic goats that lack PrPC (PRNPTer/Ter) compared with
cells from normal (PRNP+/+) goats. Spermatozoa were analyzed for freeze tolerance,
DNA integrity, viability, motility, ATP levels, and acrosome intactness at rest and after
acute stress, induced by Cu2+ ions, as well as levels of reactive oxygen species (ROS)
after exposure to FeSO4 and H2O2. Surprisingly, PrP
C-negative spermatozoa reacted
similarly to normal spermatozoa in all read-outs. Moreover, in vitro exposure of PBMCs
to Doxorubicin, H2O2 and methyl methanesulfonate (MMS), revealed no effect of PrP
C
on cellular survival or global accumulation of DNA damage. Similar results were obtained
with human neuroblastoma (SH-SY5Y) cell lines stably expressing varying levels of PrPC.
RNA sequencing of PBMCs (n= 8 of PRNP+/+ and PRNPTer/Ter) showed that basal level
expression of genes encoding DNA repair enzymes, ROS scavenging, and antioxidant
enzymes were unaffected by the absence of PrPC. Data presented here questions the
in vitro cytoprotective roles previously attributed to PrPC, although not excluding such
functions in other cell types or tissues during inflammatory stress.
Keywords: prion protein, stress resilience, spermatocytes, peripheral bloodmononuclear cells, goatmodel, testes,
ROS stress
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INTRODUCTION
The cellular prion protein (PrPC) is the substrate for prion
propagation in which the protein is misfolded to the pathogenic
scrapie conformer (PrPSc) (Prusiner, 1993). Neurons have
limited capacity to degrade or otherwise dispose safely of PrPSc,
which ultimately causes their demise. Aggregates of PrPSc,
containing infectious prions, in the central nervous system (CNS)
and to varying degrees in peripheral organs, are pathognomonic
for incurable prion diseases such as Creutzfeldt Jakob disease
in humans, scrapie in sheep, and chronic wasting disease in
deer (Aguzzi and Calella, 2009). Understanding the physiological
function of PrPC is important for deciphering the pathogenesis
of prion diseases and for development of prevention strategies.
During its synthesis, PrPC is translocated into the
endoplasmic reticulum and the secretory pathway. It undergoes
several post-translational modifications, including attachment
of two N-glycans and a C-terminal glycosylphosphatidylinositol
(GPI) anchor that ultimately tethers the protein to the outer
leaflet of the plasma membrane (Stahl et al., 1987). Many aspects
concerning PrPC’s sub-cellular localization, post-translational
modifications, and participation in various cellular processes are
still incompletely understood.
The protein is abundantly present in the central and
peripheral nervous system, but also, at lower levels, in most other
tissues. The widespread expression of the gene encoding PrPC
(Prnp) already during embryonal development (Manson et al.,
1992; Tremblay et al., 2007) and in adult animals (Bendheim
et al., 1992), suggests that it functions in diverse physiological and
cellular contexts. Initial analysis of mice with genetic knockout
of PrPC (Prnp−/−) showed that they developed and remained
healthy without displaying any aberrant phenotypes (Bueler et al.,
1992; Manson et al., 1994), apart from being completely resistant
to prion disease (Büeler et al., 1993). Subsequently, a large
catalog of putative PrPC functions has evolved, including that
PrPC is cytoprotective (Mitteregger et al., 2007). Experiments
involving hypoxic brain damage (McLennan et al., 2004; Weise
et al., 2004, 2006; Shyu et al., 2005; Spudich et al., 2005)
or severe inflammation, such as experimental autoimmune
encephalomyelitis (Tsutsui et al., 2008; Gourdain et al., 2012)
or experimentally induced colitis (Martin et al., 2011) showed
that pathologies were exacerbated in animals without PrPC
expression.
By exposing cells to various forms of stress in vitro, it has been
demonstrated that PrPC contributes to cellular protection by
modulating different pathways. For instance, through inhibition
of Bax-mediated apoptosis (Kuwahara et al., 1999; Bounhar et al.,
2001; Roucou et al., 2005), or by stimulation of pro-survival
signaling (Chiarini et al., 2002; Lopes et al., 2005) through cell-
surface interaction with the extracellular co-chaperone Sti1. It
has also been shown that PrPC can contribute to increased
antioxidant defense (Brown et al., 2002; Rachidi et al., 2003;
Haigh et al., 2015) and upon translocation to the cell nucleus
to augmented AP endonuclease 1-driven DNA repair (Bravard
et al., 2015). There are also examples in the literature of
PrPC conferring variable (Yu et al., 2012) and even reduced
(Paitel et al., 2003) viability under certain conditions of stress.
Despite the perplexing pleiotropy in PrPC functions, several
lines of evidence, derived from different experimental modalities,
converge in highlighting the importance of the Cu2+-binding N-
terminal domain of PrPC for its protective properties (Dupiereux
et al., 2008; Guillot-Sestier et al., 2009; Haigh et al., 2015).
Importantly, this part of PrPC can be liberated through
proteolytic cleavage in response to oxidative stress (McMahon
et al., 2001; Watt et al., 2005).
PrPC is present at relatively high levels in the testicles,
epididymis, and seminal fluid, and at lower levels, on the surface
of ejaculated spermatozoa (Shaked et al., 1999; Ford et al., 2002;
Peoc’h et al., 2002; Fujisawa et al., 2004). It has been observed that
spermatozoa derived from Prnp−/− mice are highly susceptible
to Cu2+-induced oxidative stress compared with wild-type mice
(Shaked et al., 1999), suggesting that PrPC by virtue of its Cu2+-
binding properties contributes significantly to the protection
of spermatozoa against reactive oxygen species (ROS) stress;
however, not critical for fertility.
Taken together, the mechanisms of PrPC-mediated stress
protection are incompletely understood and previously assigned
stress-protective roles of PrPC have recently been questioned
(reviewed in Castle and Gill, 2017), pointing to the need for
reassessment and cross-validation by newly developed animal
models. In the present investigation, we addressed this by
examining oxidative and genotoxic stress resilience of ejaculated
spermatozoa and circulating mononuclear cells derived from
a naturally occurring line of goats that completely lack PrPC
(PRNPTer/Ter) in comparison with wild-type goats of the same
breed (Benestad et al., 2012). Animals carrying the PRNPTer
allele do not display aberrant behavior, such as anxiety, or other
clinically recognizable phenotypes. However, detailed analysis
at resting state (Reiten et al., 2015; Malachin et al., 2017) and
under inflammatory stress induced by lipopolysaccharide (LPS)
(Salvesen et al., 2017) have provided data suggesting that PrPC
has a modulatory role in certain immunological pathways, such
as type I interferon signaling.
MATERIALS AND METHODS
Animals and Sample Material
Age-and gender-matched goats of the Norwegian Dairy Goat
breed born between February–March 2016, and genotyped as
either normal (PRNP+/+) or PrPC deficient (PRNPTer/Ter), were
included in the study. Animals were held in a farmhouse
environment and showed no signs of abnormal health issues
throughout the sampling period. The study was approved by
the Committee on the Ethics of Animal Experiments by The
Norwegian Animal Research Authority (ID No. 8058).
Semen Collection and Cryopreservation
Two groups of bucks, PRNP+/+ (n= 4) and PRNPTer/Ter (n= 4)
genotypes, with mean age 208 and 223 days, respectively, were
used. The bucks were housed at the Norwegian sheep and goat
breeders AI station at Hjermstad (Norway), and allowed an
acclimatization period of 2 weeks. Following a training period,
semen samples were successfully collected using an artificial
vagina while the bucks were mounting an estrous goat.
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The volume of the ejaculates was registered, after which
the spermatozoa concentration was quickly assessed by
spectrophotometer in order to determine the correct dilution
factor to attain a standardized concentration of 800 × 106
spermatozoa/ml. The ejaculates were kept at 35◦C for 10min,
before dilution to a final volume of 15ml using AndroMed R©
(Minitübe, Tiefenbach, Germany) extender. After 15min at
room temperature, the ejaculates were placed in a water bath at
5◦C and kept at this temperature for 2 h, prior to centrifugation
at 800 × g for 10min. Some of the supernatant was carefully
removed leaving the final pre-calculated volume. Spermatozoa
were re-suspended by gentle mixing before filling into 0.25ml
French mini straws (IMV, L’Aigle, France). The straws were
placed on ramps and cryopreserved by a cooling rate of 2◦C/min
from +5◦ to −10◦C and from −10◦ to −150◦C with cooling
rate of 40◦C/min, and thereafter plunged into liquid nitrogen
(LN2). The straws were put in goblets and stored in LN2. When
semen collection was finalized, the bucks were euthanized by
an intravenous injection of pentobarbital (Euthasol vet, Richter
Pharma, Austria) and tissue samples were immediately collected
and treated as specified for subsequent storage and analysis.
Immunohistochemistry and
Immunofluorescence of Testicle and
Epididymis
For PrPC detection in the testicle and epididymis, tissues from
one buck of each genotype were used. Tissues were snap frozen
in liquid nitrogen and stored at −80◦C. Cryosections (12µm)
were taken of frozen tissue samples and the slides allowed to dry
before further use. Tissue sections were fixed in formolcalcium
prior to antibody labeling. Washing with PBS followed after each
step. PRNPTer/Ter tissue functioned as negative control.
For immunohistochemistry (IHC), an Envision anti-mouse
kit (Dako, Agilent, Santa Clara, CA) was used for endogenous
peroxidase blocking following the manufacturer’s procedures.
Goat serum was added for Fc blocking prior to incubation
with primary antibodies for 45min. For IHC, anti-prion
antibodies 6H4 (mouse IgG1k, Prionics, ThermoFisher Scientific,
Waltham, MA) and SAF32 (mouse IgG2b, SpiBio, Bertin
pharma, Montigny le Bretonneux, France) were used, while for
immunofluorescence (IF), 6H4 only was used. Secondary anti-
mouse antibodies from the kit were added for 45min, and
stained with 3,3′-Diaminobenzidine (DAB), before mounting
with aqueous medium. All slides were evaluated by standard light
microscopy and photos were taken with a Leica EC3 camera
(Leica Camera AG, Wetzlar, Germany).
For IF, goat serum was added for Fc blocking prior to
incubation with primary antibodies for 3 h. 6H4 (mouse IgG1k)
was used to detect PrPC and c-kit/CD117 (rabbit polyclonal,
Dako, Agilent) was used to detect germ cells. Secondary
antibodies for PrPC (Alexa 488 IgG1 goat anti-mouse, Molecular
Probes, ThermoFisher Scientific) and c-kit (Alexa 594 IgG (H+L)
goat anti-rabbit, Molecular Probes, ThermoFisher Scientific)
were allowed to incubate for 1 h. ProLongTM Diamond Antifade
Mountant with DAPI (ThermoFisher Scientific) was used for
mounting and nuclei staining. Fluorescence was visualized with
an Axio Imager 2 Research Microscope (Zeiss, Oberkochen,
Germany) and images were processed in Zen (Zeiss).
Histochemistry for Lipids with Oil Red O
Four bucks of each genotype were investigated. Cryosections
from the testicle were fixed by a mixture of 40% formaldehyde
and 70% ethanol 1:9 v/v for 5min and stained by a standard
protocol [Oil red O (ORO), Schmid GMBH & Co]. Slides were
counterstained with hematoxylin and mounted with aqueous
medium before evaluation by standard light microscopy.
Western Blot
To remove seminal plasma prior to analysis, spermatozoa from
one straw of each genotype were washed twice in 1ml of PBS by
centrifugation at 800 rpm for 5min, followed by careful removal
of the supernatant. Washed spermatozoa and testicle tissue
samples were lysed in homogenizer buffer (Tris HCl 50µM,NaCl
150mM, EDTA 1mM, DOC 0.25%, NP40 1%) supplemented
with protease inhibitor cocktail 2x (Complete, Roche, Merck Life
Science, Darmstadt, Germany). Twenty micrograms of protein,
measured by the Protein assay (Bio-Rad, Hercules, CA), were
deglycosylated with PNGase-F according to the manufacturer’s
instructions (New England Biolabs, Ipswich, MA). Twenty
micrograms of protein and the deglycosylated samples were
mixed with SDS Loading buffer and Sample Reducing agent
(Invitrogen, ThermoFisher Scientific), heated for 10min at 95◦C
before separation by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (12% Criterion gel, Bio-Rad), and transferred to
a polyvinylidene difluoride (PVDF) membrane (GE Healthcare,
Chicago, Il). Membranes were blocked in 5% milk TBST, and
probed with primary antibodies; P4 mouse anti-PrPC antibody
(Ridascreen Biopharm, Darmstadt, Germany) 1:100, anti-c-
kit/CD117 (rabbit polyclonal, Dako, Agilent) 1:500 and anti-beta
Actin (Mouse monoclonal, ThermoFisher Scientific, Waltham,
MA, USA) 1:20,000. Secondary anti-mouse or anti-rabbit
antibodies conjugated with Alkaline Phosphatase (AP) were used
for the detection, developed with Enhanced chemiluminescence
(ECF) reagent (GE Healthcare) and Typhoon 9200 (Amersham
Bioscience, GE Healthcare).
CuCl2 Treatment of Spermatozoa
Two straws from each buck were thawed in a water bath at 35◦C
for 30 s. The pooled straws were aliquoted, and CuCl2 was added
and gently mixed. Three concentrations of CuCl2 were used (100,
150, or 200µg/ml), while no addition served as control. A stock
solution of 1 mg/ml CuCl2 in PBS was used in combination with
pure PBS to obtain the two concentrations. Semen samples were
analyzed after 0, 30, 60, 90, and 120min incubation at 35◦C.
Plasma Membrane and Acrosome Integrity
Analysis of Spermatozoa
Spermatozoa plasma membrane integrity (spermatozoa
viability) was assessed using Propidium iodide (PI, L-
7011, LIVE/DEAD R©Sperm Viability Kit, Molecular Probes,
ThermoFisher Scientific) to discriminate between live and
dead (PI positive) spermatozoa. The proportion of acrosome
reacted/degenerated spermatozoa was identified using the
Frontiers in Molecular Biosciences | www.frontiersin.org 3 January 2018 | Volume 5 | Article 1
Reiten et al. Prion Protein Stress Resilience
peanut (Arachis hypogaea) agglutinin (PNA) lectin conjugated
with Alexa Fluor R© 488 (PNA-Alexa 488, L21409, Invitrogen,
ThermoFisher Scientific). Prior to flow cytometry analysis, the
spermatozoa were stained for 10min at room temperature in a
PBS staining solution with a final concentration of ≈1.5 × 106
spermatozoa/ml, 0.47µM PI and 49 ng/ml PNA. Four replicates
of each semen sample were analyzed. The reliability of the
PI staining was confirmed in control samples double stained
with both PI and SYBR-14 (Molecular Probes, ThermoFisher
Scientific). Upon staining, analysis of the spermatozoa was
performed using a Cell Lab Quanta TM SC MPL flow cytometer
(Beckman Coulter, Fullerton, USA). The instrument was
equipped with a 22 mW argon laser with excitation at
488 nm. Data was analyzed using Cell Lab Quanta SC MPL
Analysis software program (Beckman Coulter). To identify the
spermatozoa, a combination of electronic volume (EV) and side
scatter (SS) signals were used, as described by Standerholen
et al. (2014). Fluorescence detection and gating of the acrosome
intact (AI) and acrosome intact live (AIL) spermatozoa was also
performed according to Standerholen et al. (2014).
Spermatozoa Motility Analysis by CASA
Spermatozoa motility analysis was performed using Sperm
Class Analyzer (SCA Evolution, version 6.1; Microptic S.L.,
Barcelona, Spain) CASA system. Threemicroliters of each sample
was loaded into a pre-warmed (37◦C) standardized Leja 4-
chamber microscope slide (Leja products, Nieuw-Vennep, The
Netherlands) and analyzed using a phase contrast microscope
(Nikon Eclipse, Nicon Group, Japan) equipped with Basler digital
camera (Basler Vision Technologies, Basler AG, Ahrensburg,
Germany). For each semen sample (n = 4), two replicates were
analyzed, and for each replicate, eight microscopic fields were
scanned, with a total of at least 500 cells per sample, and mean of
the eight fields was presented. The motility parameters analyzed
were total motility and progressive motility. The instrument
settings for the analysis were; spermatozoa head area between 25
and 75 µm2; frame rate of 25 frames/s; immotile spermatozoa
defined with an average path velocity below 10 µm/s.
Assessment of ATP Content
The ATP content was determined using the CellTiter-Glo R©
Luminescent Cell Viability Assay (Promega, Madison, WI). This
method was previously adopted for the evaluation of the ATP
content in boar semen (Long and Guthrie, 2006); however,
the optimal spermatozoa number for analysis of goat semen
was determined in the present study. For preparation of ATP
standard curve samples, ATP disodium salt hydrate (A7699-
1G, Sigma-Aldrich, Merck Life Science) was prepared in PBS to
obtain the following ATP concentrations: 0, 40, 80, 200, 800, and
1,000 nM. Prior to analysis, goat semen was diluted to 1.5 × 106
spermatozoa/ml in PBS, and 50 µl samples transferred to wells
in a white 96-well microtiter plate (NUNCTM, ThermoFisher
Scientific). Subsequently, 50 µl CellTiter-Glo R© Reagent was
added to each well and the mixture was gently shaken for 2min
in a rotary shaker to induce cell lysis. After further incubation
for 15min at room temperature, bioluminescence measurement
was performed using a FLUOstar OPTIMAmultiwell plate reader
(BMG LABTECH GmbH, Offenburg, Germany) with MARS
data analysis software (Version 1.10, BMG LABTECH GmbH).
Software setting was luminescence mode with gain 2900 and
measurement time interval 0.5 s. By use of the ATP standard
curve, the bioluminescence value for each sample, measured
in relative luminescence units (RLU), was converted to the
corresponding ATP-value in nM. An average of three replicates
was used for statistical analysis.
ROS Analysis of Spermatozoa
One semen straw from each buck was thawed for 8 s in
a 70◦C water bath. The spermatozoa concentration was
measured and the semen was diluted in PBS prior to staining
with fluorescence markers to a final concentration of 5 ×
106 spermatozoa/ml. Hoechst 34580 (1.25µM, Invitrogen,
ThermoFisher Scientific) and Mitotracker Orange CMTMRos
(MO, 0.15µM, Invitrogen, ThermoFisher Scientific) were used
to eliminate non-spermatozoa events based on DNA and
mitochondrial staining, respectively. Propidium Iodide (PI,
5µg/ml, Invitrogen, ThermoFisher Scientific) was used to
discriminate between plasma membrane-intact and degenerated
spermatozoa, while CellROX R©Deep Red Reagent (CRR, 5µM,
Invitrogen, ThermoFisher Scientific) was used to assess levels of
ROS as a measure of cellular oxidative stress.
Basal levels of ROS as well as levels after induction of oxidative
stress was assessed, both in duplicate samples. Semen samples
were subjected to oxidative stress with 500µM FeSO4·7H2O and
196µM H2O2 to induce the Fenton reaction. At the same time
point, the CRR and the Hoechst were added and the samples
were incubated for 15min at room temperature, after which, the
markers MO and PI were added and the samples were incubated
for another 15min.
The semen samples were analyzed on a Navios flow cytometer
(Beckman Coulter) equipped with a 488 nM (blue), a 638 nM
(red), and a 405 nM (violet) diode laser. The twomarkersMO and
PI were exited using the blue laser and fluorescence emission was
collected using a 560–590 BP filter (FL2) and a 680–700 nM BP
filter (FL4), respectively. Hoechst 34580 was exited using the blue
laser and CRR using the red laser, while fluorescence emission
was detected using a 530–570 nM BP filter (FL10) and a 650–
670 nM BP (FL6), respectively. The instrument was checked daily
for optical alignment by running Flow-Check beads (6605359,
Beckman Coulter). An unstained semen sample was included
as negative fluorescence control. Compensation was performed
prior to collection of data with unstained semen samples and
samples stained singularly with each fluorescence marker.
The flow cytometry-generated data were analyzed in FCS
express software analysis program (De Novo Software, Canada).
Computer-defined gates were set in a cytogram of Hoechst
vs. MO to identify the spermatozoa (Hoechst and MO
positive). Spermatozoa viability, defined as spermatozoa with
a functional mitochondrial staining (MO-positive) and intact
plasma membrane (PI negative), was estimated by use of an
MO vs. PI cytogram. A cytogram of CRR vs. PI was used to
determine the proportions of spermatozoa with different levels
of ROSwithin the viable spermatozoa population (i.e., non-viable
spermatozoa were excluded, Figure 4).
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Collection of PBMCs
Blood samples from animals of both genotypes were collected
from the jugular vein into EDTA tubes and kept at room
temperature until analysis. Peripheral blood mononuclear cells
(PBMCs) were harvested and cultured as previously described
(Reiten et al., 2015). For the PBMC experiments, cells from
individual animals were used as biological replicates. A total
of four animals of each genotype were included in the
experiments with oxidative stressors, and the experiment was
repeated once with four of the same animals, two of each
genotype.
SH-SY5Y Cell Culture
Human neuroblastoma SH-SY5Y cells (Sigma-Aldrich, Merck
Life Science) were cultured and transfected with a plasmid
construct encoding human PRNP as previously described
(Malachin et al., 2017). Cells were allowed to grow for 48 h before
stress exposure.
Oxidative and Genotoxic Stress
PBMCs and SH-SY5Y cells were exposed to the alkylating agent
methyl methanesulfonate (MMS, Sigma-Aldrich, Merck Life
Science) (PBMCs: 0.5mM; SH-SY5Y: 1.5mM) and doxorubicin
(Sigma-Aldrich, Merck Life Science) (PBMCs: 3µM; SH-
SY5Y: 2µM) to induce DNA damage; methyl groups on
nucleophilic sites of DNA bases and double-strand breaks
(DSBs), respectively. To induce oxidative stress, cells were
cultured with hydrogen peroxide (H2O2, Sigma-Aldrich, Merck
Life Science) (PBMCs: 75µM; SH-SY5Y: 150µM). MMS was
routinely removed from wells after 1 h and new culture media
was added for recovery. Cells were incubated in 5% CO2, at
37◦C, with their respective stressors for the designated amount of
time.
Viability of PBMCs
To analyze viability after stress exposure (H2O2, doxorubicin,
MMS) in cells with or without PrPC, PBMCs (both genotypes:
n = 4; 3 × 105 cells/well), and SH-SY5Y cells (non-transfected
and transfected cells: n= 3; 104 cells/well) were cultured in a 96-
well Greiner plate (Sigma-Aldrich, Merck Life Science) for a total
of 24 h.
The average survival of the PBMCs from these four animals
were included in the analysis. For SH-SY5Y cells, the experiment
was repeated three times. Cell survival after 24 h was quantified
using the Alamar Blue exclusion method and the fluorescence
was read at 495 nm by Cytation 3 reader (BioTek Instruments,
Winooski, VT).
To avoid the impact of differences in cell count, all stressed
cells were compared to their own control, and expressed as
percentage.
PRNP Transcriptional Expression
PBMCs were added to 6-well plates (5 × 106 cells/well) and
exposed to MMS, H2O2, and doxorubicin, as described above.
Cells were harvested after 1, 3, 6, and 24 h of exposure (1 h
exposure with MMS, with recovery) and washed once with PBS
containing 2mM EDTA.
SH-SY5Y cells were plated and exposed in flasks (7.5 × 106
cells/flask), followed by scraping in 1ml of PBS.
All cell pellets were frozen in−70◦C.
RNA and DNA Isolation, RT-qPCR
Total DNA was isolated from PBMCs and SH-SY5Y cells using
a DNeasy Blood and tissue kit (Qiagen, Germantown, MD).
Total RNA was isolated from frozen cell pellets using an RNeasy
mini plus kit (Qiagen), following the manufacturer’s instructions
and quantified using a NanoDrop-1000 Spectrophotometer
(ThermoFisher Scientific), prior to cDNA synthesis using
SuperScriptTM-III reverse transcriptase, dNTPs mix, First-
Strand Buffer, DTT, RNAse OUTTM (Invitrogen, ThermoFisher
Scientific) and 500 ng of total RNA.
Quantitative PCRwas performed using a LightCycler 480 Sybr
Green I Master mix (Roche Holding AG, Basel, Switzerland)
and run on a LightCycler 96 System (Roche), with the following
primers PRNP (goat) F:GTGGCTACATGCTGGGAAGT, R:
AGCCTGGGATTCTCTCTGGT; PRNP (human) F:CTGCTG
GATGCTGGTTCTCT, R:GTGTTCCATCCTCCAGGCTT. See
Malachin et al. for further details (Malachin et al., 2017).
DNA Damage Analysis: LC-MS/MS
Quantification of 8-oxo(dG) and 7-m(dG)
DNA samples were digested by a mixture of nuclease P1
from Penicillium citrinum (N8630, Sigma-Aldrich, Merck
Life Science), DNaseI (04716728001, Roche), and ALP from
E. coli (P5931, Sigma-Aldrich, Merck Life Science) in 10mM
ammonium acetate buffer pH 5.3, 5mMMgCl2, and 1mMCaCl2
for 30min at 40◦C. The samples were methanol precipitated,
supernatants were vacuum centrifuged at room temperature until
dry, and dissolved in 50 µl of water for LC/MS/MS analysis.
Quantification was performed with an LC-20AD HPLC system
(Shimadzu, Kyoto, Japan) coupled to an AB Sciex API 5000 triple
quadrupole (McKinley scientific, Sparta, NJ) operating in positive
electrospray ionization mode. The chromatographic separation
was performed with the use of a Supelco Ascentis Express C18
2.7µm 150 × 2.1mm i.d. column protected with a Supelco
Ascentis Express Cartridge Guard Column (both from Ascentis,
Sigma-Aldrich, Merck Life Science) with an Exp Titanium
Hybrid Ferrule (Optimize Technologies Inc., Oregon City, OR).
The mobile phase consisted of A (water, 0.1% formic acid)
and B (methanol, 0.1% formic acid) solutions. The following
conditions were employed for chromatography: for unmodified
nucleosides—0.13 ml/min flow, starting at 10% B for 0.1min,
ramping to 60% B over 2.4min, and re-equilibrating with 10%
B for 4.5min; for 8-oxo(dG)—0.14 ml/min flow, starting at 5% B
for 0.5min, ramping to 45% B over 8min, and re-equilibrating
with 5% B for 5.5min. For mass spectrometry detection, the
multiple reactionmonitoring (MRM)was implemented using the
following mass transitions: 252.2/136.1 (dA), 228.2/112.1 (dC),
268.2/152.1 (dG), 243.2/127.0 (dT), 284.1/168.1 [8-oxo(dG)].
Transcriptomics
For transcriptomic analysis, PBMCs were harvested from 8
PRNP+/+ and 8 PRNPTer/Ter age-matched animals and RNA was
isolated. RNA samples of high quality were shipped to Beijing
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Genomics Institute (BGI), Hong Kong. Paired-end sequencing
was conducted on an Illumina HiSeq 2000 with 91 bp read-
length, retrieving 5G clean data per sample. Raw data were
analyzed using EdgeR (Robinson et al., 2010). For further details
of the study protocol and analysis (see Malachin et al., 2017).
All FASTQ files are available from the SRA database (SRA study
accession number SRP102642).
Gene expression of enzymes involved in antioxidant defense
and DNA damage repair were analyzed, specifically those
involved in base excision repair (BER), nucleotide excision repair
(NER), mismatch repair (MMR), and DSB repair.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism
version 6.07 (Graphpad, La Jolla, CA). Statistical significance was
evaluated by multiple t-tests using the Holm-Sidak correction
and p < 0.05 were regarded significant.
RESULTS
PrPC Is Abundantly Expressed in the
Testicle and Present on Spermatozoa
To evaluate the physiochemical properties of PrPC in the testicle
and spermatozoa, we performed Western Blot (WB) analysis
from PRNP+/+ and PRNPTer/Ter bucks (Figure 1A, uncropped
image available in Supplementary Materials). In PRNP+/+
samples not treated with PNGaseF, high molecular weight bands
were present, apparently dominated by diglycosylated, full-length
PrPC. Glycosylated PrPC from testicle appeared heavier than
in spermatozoa, probably reflecting differences in composition
of the glycan moieties. After PNGase-F digestion, full length
PrPC at 27 kDa and a band of approximately 18 kDa were
recovered from both spermatozoa and testicular tissue derived
from the PRNP+/+ animals. The 18 kDa band corresponds
well with a C-terminal fragment known as the C2 fragment
derived after proteolytic processing of PrPC in the octapeptide
repeated sequence. Two further bands, particularly prominent
in the preparations from spermatozoa with corresponding
molecular masses at about 22–24 kDa, could represent PrPC
truncated from the C-terminus. Further studies are needed to
clarify this.
Analysis by IHC on testicles from PRNP+/+ bucks
(Figures 1B,C) showed strong interstitial PrPC staining in
a pattern suggesting that both Leydig cells and connective
tissue express PrPC. Along the basement membrane of the
seminiferous tubules, a distinct PrPC-negative zone was noted.
Inside the seminiferous tubules, PrPC was distributed from
the basement membrane through to the lumen in between the
spermatogenic cell nuclei that in most developmental stages of
the seminiferous cycle (França et al., 1999) were surrounded
by a weakly stained or non-stained zone, indicating that the
cytoplasm of the immature spermatogenic cells contains little
PrPC. The staining pattern indicated that the Sertoli cells harbor
PrPC in their cytoplasm, including along the rim of peripherally
located vacuoles and in projections toward the center of the
tubules. PrPC was not detected by IHC on tissue sections from
PRNPTer/Ter bucks (Figure 1D). Immunofluorescent staining
for PrPC and c-kit (CD117) with DAPI for identification
of nuclei (Figures 2A–C) confirmed the pattern of PrPC
distribution in the testicles of PRNP+/+ bucks. The c-kit+
spermatogonia close to the basement membrane showed weak
PrPC immunostaining, while the strongest signals were found
in aggregates of small vesicles on the luminal side consistent
with residual bodies; cytoplasmic droplets released from
maturation phase spermatids and quickly engulfed by Sertoli
cells. Immunolabeling was also seen through the tubular wall
between cells to the basement membrane with the conspicuous
peripheral PrPC-decorated vacuoles (Figure 2G), as also noted
by IHC. Histochemical staining with ORO suggests that the
PrPC-labeled vacuoles contain lipids (Figures 2H,I), described
as a normal constituent of Sertoli cells (Wang et al., 2006).
Lipid vacuoles were found at various stages. Interestingly, in
association with the largest vacuoles, a significant number of
small vesicles were present, some even outside the tubule in
the basement membrane or the interstitial tissue. In stages
of the spermatogenic cycle with abundant mature elongated
spermatids, abundant small ORO-stained vesicles were located
among the spermatids (Figure 2H), while after the release
of the spermatids, the ORO staining toward the lumen was
less prominent (Figure 2I). In PRNPTer/Ter bucks, PrPC was
not detected, whereas the c-kit labeling (Figures 2D–F) and
ORO staining (data not shown) was similar as in the testicles
of the PRNP+/+ bucks. The expression pattern of PrPC in
epididymis was established by IHC and IF (Supplementary
Figure 1), both showing a strong staining of round basal cells
within the epididymal epithelium and interstitial connective
tissue. Smooth muscle cells stained weakly for PrPC. Tissues
from PRNPTer/Ter bucks were negative by both methods. Global
testicular levels of c-kit was assessed by WB and showed similar
levels between the genotypes (Supplementary Figure 5 and
uncropped image).
Spermatozoa from PRNPTer/Ter and
PRNP+/+ Bucks Show Similar Stress
Responses
To assess whether spermatozoa cells suffer from loss of PrPC
during an increase in ROS stress, we analyzed acrosome
intactness, semen ATP levels and motility in CuCl2-treated and
non-treated spermatozoa from PRNP+/+ and PRNPTer/Ter bucks
(Figure 3). There was a clear dose-and time-dependent effect of
CuCl2 in all experiments.
The acrosome intactness of non-treated spermatozoa did not
differ between the genotypes and was consistent at ≈80% AI
and ≈40% spermatozoa with intact acrosome live throughout
the length of the experiment (Figures 3A,B). Treatment with
100µg/ml CuCl2, on the other hand, resulted in a distinct
decline in intact spermatozoa (Figure 3A). Importantly, there
were no differences between the genotypes (Significance tested
by multiple t-test with Holm-Sidak correction). In living
spermatozoa, intactness seemed to increase during the first
30min in both treated and non-treated cells, most likely due to a
gradual decrease in permeability that stabilizes during incubation
(Figure 3B).
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FIGURE 1 | PrPC is expressed in testicular tissue and spermatozoa. PrPC was detected in testicle and spermatozoa by Western blot (WB) (A) and
Immunohistochemistry (IHC) (B–D) using the P4 and 6H4 antibodies, respectively. In WB (A), glycosylated full-length PrPC is detected in both spermatozoa and
testicular tissue. After deglycosylation with PNGaseF, several bands are visible on both preparations, including bands of approximately 25 and 18 kDa molecular
mass, probably corresponding to full length PrPC and a C-terminal fragment, respectively. Further bands with apparent molecular mass of 22–24 kDa are particularly
prominent in samples from spermatozoa. No PrPC could be detected in samples from PRNPTer/Ter animals. By IHC, a distinct PrPC staining of seminiferous tubules
with positive Sertoli cells, including the rim of vacuoles (white arrowheads) was observed. Spermatocytes (B) black arrowheads, and round spermatids (C) black
arrowheads appeared negative for PrPC. Testicular tissue from PRNPTer/Ter bucks (D) are completely unstained, but similar in architecture and the presence of
vacuoles (white arrowheads). The basement membrane of seminiferous tubules is indicated by dots, and the lumen by asterisk. (B–D): x400. Scale bars 25µm.
Non-treated spermatozoa cells had a slow decline in ATP
whereas CuCl2 treatment resulted in a rapid decline with ATP
levels reaching zero after 60min (Figure 3C).
Similar findings were observed after motility tests. Total and
progressive motility from both genotypes declined during a
120min interval (Figures 3D,E). The starting motility at time 0
was 30.6 and 36.0%, for PRNP+/+ and PRNPTer/Ter, respectively.
CuCl2 severely affected the spermatozoa total and progressive
motility, which dropped to low levels after 60min (100µg/ml)
(Figures 3D,F).
ROS Detection in Spermatozoa
To evaluate whether spermatozoa without PrPC react differently
to oxidative stress induced by H2O2 in combination with FeSO4,
levels of ROS were assessed by flow cytometry using CRR
prior to and after oxidation (Figure 4). Incubating spermatozoa
for 30min with 500µM FeSO4·7H2O and 196µM H2O2 did
not induce cell death as there were no differences in viability
before and after exposure. Before ROS exposure, the percentage
of viable cells was 39.19 ± 4.98 in the PRNP+/+ group and
37.75 ± 3.65 for the PRNPTer/Ter animals. The corresponding
values after ROS exposure were 39.66 ± 3.69 and 35.58 ±
3.67 for the PRNP+/+ and PRNPTer/Ter group respectively (n
= 4, all groups). Viable cells were discriminated according
to accumulated ROS levels; dim, intermediate or bright. A
shift in fluorescence signal reflecting different levels of ROS
in PRNP+/+ vs. PRNPTer/Ter spermatozoa was detected in all
regions (Figures 4C,F). Approximately 75% of the PRNP+/+
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FIGURE 2 | PrPC is distinctly present in lipid vesicles and vacuoles in seminiferous tubules. Immunofluorescence analysis of testicular tissue demonstrates the
presence of PrPC (A) green, and the stem-cell marker c-kit (B) red, cell nuclei counterstained with DAPI (blue) and merged (C) in PRNP+/+ bucks. Spermatogenic
stem cells positive for c-kit+ were distributed along the basement membrane and appeared to express low levels of PrPC. However, PrPC was prominently present in
small vesicles on the luminal aspect and in larger Sertoli cell vacuoles (arrowheads) along the periphery of the tubules, as highlighted by digital magnification (G) of
rectangle depicted in (A). Both the vesicles and vacuoles (arrowheads) contain lipids, as shown by ORO-staining (H,I). Testis from PRNPTer/Ter bucks is negative for
PrPC and show similar distribution of c-kit and harbor similar vacuoles (arrowheads) as PRNP+/+ bucks (D–F). Asterisk: Lumen of seminiferous tubules. x400 (all
except G which was digitally magnified to x1,000). Scale bars 25µm.
spermatozoa fell into the bright region, indicating high ROS
levels, as compared to only 24.38% of the PRNPTer/Ter
spermatozoa, after induction of oxidative stress. The results
indicate that PRNP+/+ spermatozoa accumulated higher levels of
ROS than PRNPTer/Ter cells but even so, the viability was similar
between the genotypes.
Viability of Peripheral Blood Mononuclear
Cells with and without PrPC Expression
upon Cellular Stress Exposure
Considering that spermatozoa cells are highly specialized cells
expressing only limited sets of proteins, we decided to include
other cell types in the study of PrPC’s role in in vitro stress
resilience. Thus, we measured the relative viability 24 h after
treatment with MMS (1 h with 23 h recovery), H2O2 and
doxorubicin (both 24 h treatment) in primary PBMCs from
both genotypes, and human neuroblastoma cell line SH-SY5Y
cells and hu-PrP SH-SY5Y cells, stably expressing moderate
(80- to 100-fold, mRNA) higher levels of PrPC than un-
transfected SH-SY5Y cells, which express very low levels of PrPC.
Human neuroblastoma cells were included for analysis of PrP-
associated phenotypes in a neuronal cell line, different from
goat immune cells and spermatozoa. Surprisingly, viability was
significantly higher in PRNPTer/Ter PBMCs after both H2O2
and MMS exposure (Figure 5A). With doxorubicin, PBMCs
from both genotypes reacted similarly. No significant differences
were detected between SH-SY5Y and hu-PrP SH-SY5Y cells
(Figure 5B). The PRNP mRNA expression levels in PBMCs
increased slightly after doxorubicin treatment (Supplementary
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FIGURE 3 | Expression of PrPC does not increase viability upon induced oxidative stress in spermatozoa. Acrosome-intact spermatozoa (A), acrosome-intact viable
spermatozoa (B), ATP levels (C), total motility (D), and progressive motility (E,F) were measured by flow cytometry in thawed spermatozoa from PRNP+/+ and
PRNPTer/Ter bucks (both n = 4) at 0, 30, 60, 90, and 120min after CuCl2-induced (100µg/ml) oxidative stress. Values are shown as mean ± SEM (Significance
tested by multiple t-test with Holm-Sidak correction).
Figure 2A); however, after 24 h of doxorubicin, the expression
was downregulated. No major regulation of PRNP expression
was observed with the other stressors. In both hu-PrP SH-SY5Y
and SH-SY5Y cells, a consistent but moderate upregulation of
PRNP expression was observed with all stressors (Supplementary
Figures 2B–C).
No Differences in DNA Damage Levels
after Oxidative and Genotoxic Stress
The 7-m(dG) lesions induced by MMS exposure increased
dramatically afterMMS treatment in both cell types. Importantly,
there were no differences between the genotypes (Figure 6). The
accumulation of lesions was most profoundly seen in SH-SY5Y
cells, although the levels of 7-m(dG) after 1 h (data not shown)
and 24 h were similar, indicating that the cells had reached a
maximum lesion threshold already after 1 h.
H2O2-induced oxidative stress yielded a similar amount of
8-oxoG lesions in both genotypes (Supplementary Figure 3),
indicating that the presence of PrPC is not essential to maintain
the DNA damage-repair response. Notably, in PBMCs, the major
enzymes involved in base-excision repair (BER), nucleotide-
excision repair (NER), DSB repair, and MMR displayed no
significant difference in mRNA expression levels between the two
genotypes (Supplementary Figures 4A–D). No differences were
detected in mRNA expression levels for antioxidant enzymes
either (Supplementary Figure 4E).
DISCUSSION
The expanding literature dealing with putative physiological
functions of PrPC has recently been comprehensively reviewed
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FIGURE 4 | ROS levels in spermatozoa indicates no protection from PrPC. ROS levels were measured by flow cytometry in PRNP+/+ and PRNPTer/Ter spermatozoa
after treatment with H2O2 and FeSO4 for 30min. Plots from controls (A,B) and oxidized (C,D) spermatozoa are shown for both genotypes (A,D): PRNP
+/+, (B,E):
PRNPTer/Ter. Based on fluorescence intensity, spermatozoa were gated into regions dim, intermediate and bright, of which region bright represents spermatozoa with
the highest ROS levels. Mean basal (C) ROS levels and mean ROS levels after H2O2 and FeSO4 treatment (F) in both genotypes is shown (n = 4). The percentages
of viable cells before ROS exposure were 39.19 ± 4.98 and 37.75 ± 3.67 for PRNP+/+ and PRNPTer/Ter, respectively. The corresponding values after ROS exposure
were 39.66 ± 3.69 (PRNP+/+) and 35.58 ± 3.67 (PRNPTer/Ter). Values are shown as mean ± SEM. *indicates p < 0.05 (Significance tested by multiple t-test with
Holm-Sidak correction).
(Castle and Gill, 2017; Linden, 2017; Wulf et al., 2017). Some
of the methodological challenges inherent to various animal
models, particularly concerning genetic confounders have also
been elaborated (Steele et al., 2007). Here, we have used
an alternative animal model for prion research; dairy goats
that completely lack PrPC, caused by a nonsense mutation
affecting codon 32 in the PrPC reading frame (Benestad et al.,
2012).
The potential value of goats without PrPC for breeding
purposes, specifically to combat scrapie in goats, or for the
production of “prion free” bio-products depends not only on the
production parameters, general health and fitness of the animals,
but also their fertility and reproductive capacity in breeding
systems using artificial insemination (AI) with frozen semen. In
view of data from mice demonstrating that PrPC significantly
protected spermatozoa against metal (Cu2+)-induced oxidative
stress (Shaked et al., 1999), we assumed that spermatozoa from
bucks homozygous for the PRNPTer mutation would display
increased stress sensitivity possibly leading to reduced viability
after storage in liquid nitrogen. We have observed normal
offspring after natural breeding of homozygous PRNPTer/Ter
bucks and goats, providing evidence that lack of PrPC does not
inflict a major fertility problem for the goats, which is accordance
with data from PRNP KO mice. Moreover, during the course
of this work we have performed one AI mating with semen
from a PRNPTer/Ter buck with a goat of the same genotype and
received normal offspring, indicating intact male fertility also
after cry-preservation of semen.
Analysis of ejaculated spermatozoa and samples from testicles
with WB demonstrated that PRNPTer/Ter bucks completely lack
PrPC, whereas PRNP+/+ bucks show a significant presence
of PrPC. The protein is predominantly di-glycosylated, with
somewhat heavier molecular masses in the testicle as compared
with spermatozoa preparations. Upon deglycosylation, full length
PrPC (27 kDa) and a band with an estimated molecular mass
that corresponds to the C2 cleavage product (18 kDa) of PrPC,
are recovered from both preparations. The C2 fragment stems
from ß-cleavage of PrPC, known to be stimulated by oxidative
stress, probably cleaving goat PrPC between His88 and Gly89
(McDonald et al., 2014). Since the mab used here (P4) binds
to amino acids 95–105 (Harmeyer et al., 1998), it detects the
C2 fragment of PrPC, but not the C1 fragment generated by
α-cleavage, which most likely occurs around amino acid 115
in goat PrPC (Chen et al., 1995; Tveit et al., 2005). If the 18
kDa band shown here stems from ß-cleavage of PrPC, it could
indicate that this cleavage occurs more frequently in the testicle
and spermatozoa, compared to brain, in which the C2 fragment
is at low levels. Moreover, it has been shown that PrPC can
be liberated from the cell membrane by cleavage close to the
C-terminus, generating a protein species about 4–6 kDa smaller
than full length PrPC due to the loss of the GPI anchor (Taylor
et al., 2009; McDonald et al., 2014). This might be of relevance in
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FIGURE 5 | Lack of PrPC expression does not decrease cellular viability.
Peripheral blood mononuclear cells (PBMCs) with and without PrPC
expression, and human neuroblastoma SH-SY5Y cells with very low PrPC
levels (mock-transfected) and moderate PrPC levels (stably transfected with
human PrPC), were treated for 24 h with doxorubicin (PBMCs 3µM, SH-SY5Y
2µM) or H2O2 (PBMCs 75µM, SH-SY5Y 150µM), or methyl
methanesulfonate (MMS) (PBMCs 0.5mM, SH-SY5Y 1.5mM) for 1 h, with 23 h
recovery. Viability in PBMCs (n = 4) (A) and SH-SY5Y cells (n = 3) (B) (relative
to controls) with and without PrPC expression after induction of cellular stress
with doxorubicin, H2O2 and MMS is shown, assessed by the Alamar Blue
assay using Cytation 3. Values are given as mean ± SEM. * indicates p < 0.05
(Significance tested by multiple t-test with Holm-Sidak correction).
interpreting the two distinct bands with molecular mass between
22 and 24 kDa observed in preparations from spermatozoa.
However, as demonstrated in several previous studies (Shaked
et al., 1999; Ecroyd et al., 2004), detailed epitope mapping of
PrPC species from the male genital organs and spermatozoa
is challenging, and conflicting data have emerged. Although
interesting, solving this task was outside the scope of the current
investigations.
By IHC and IF, PrPC was found most abundantly in
Sertoli cells, including in large cytoplasmic Oil-Red-O (ORO)-
positive lipid vacuoles, particularly prominent in the periphery
of the seminiferous tubules. Ford et al. (2002) showed that an
intense PrPC-positive immunostaining could be detected in lipid
droplets shed as residual bodies from the spermatozoa as part of
their maturation process. These residual bodies are phagocytosed
by the Sertoli cells and transformed into small phagolysosomal,
ORO-positive lipid vesicles (Wang et al., 2006), as found along
the luminal aspects of the tubules in the present study. As the
distribution of ORO-positive residual bodies seem to overlap
with the granular PrPC-staining, it is likely that the residual
bodies contain PrPC. Whether PrPC in residual bodies stems
from the phagocytosed spermatid-released cytoplasmic droplets,
produced by the Sertoli cell itself, or a combination of the two,
FIGURE 6 | Similar accumulation of the methyl adduct 7-meG in PBMCs and
SH-SY5Y cells with and without PrPC expression after treatment with MMS.
PBMCs (n = 3–5) (A) and human neuroblastoma SH-SY5Y cells (n = 2) (B)
with and without PrPC expression were exposed to MMS for 1 h, with 23 h
recovery. Levels of 7-meG were assessed 24 h after exposure. Data are given
as mean ± SEM (Significance tested by multiple t-test with Holm-Sidak
correction, all p > 0.05).
remains to be investigated. The large lipid vacuoles in the basal
aspect of the Sertoli cells were present in almost all stages of the
goat spermatogenic cycle (Onyango et al., 2000) and may stem
from the degradation of apoptotic spermatogenic cells (Wang
et al., 2006) and/or residual bodies (Paniagua et al., 1987). The
latter structures were positive for PrPC and ORO, and given
that the spermatogenic cells were mostly PrPC negative, a co-
transport of PrPC and lipids from the residual body stage to
the larger vacuoles seems possible. Smaller vacuoles, maybe
from degradation of the larger vacuoles, were observed to
disseminate across the basement membrane, similar to the way
immunogenic antigens are transported (Krawetz et al., 2009).
Studies have found PRNPmRNA in several developmental stages
of spermatozoa and in Sertoli cells (Ford et al., 2002; Fujisawa
et al., 2004).
PrPC has been detected in the Sertoli cells of immature
goat bucks (130 days post conception) and in ejaculated buck
spermatozoa (Allais-Bonnet et al., 2016). Levels of PRNP mRNA
were high in buck testicular tissue from birth and gradually
decreased to reach a steady level at puberty. This observation
might suggest that PrPC in the testicle serves roles that are not
specific to spermatogenesis. This is in contrast to the prion-like
protein Doppel (Dpl), encoded by Prnd, which is expressed at
low levels in sexually immature bucks, before raising sharply
in expression toward puberty, after which it remains at a high
level (Peoc’h et al., 2002; Espenes et al., 2006; Kocer et al.,
2007). Interestingly, genetic knockout of Prnd renders male
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mice infertile (Behrens et al., 2002), whereas absence of PrPC
apparently has no direct effect on male fertility, neither in mice
nor in goat bucks (Bueler et al., 1992).
It has been proposed that PrPC is present in spermatocytes
and spermatids; although absent in the earlier spermatogonia
(Peoc’h et al., 2002). Our data demonstrate high PrPC levels
in Sertoli cells, raising the intriguing possibility that PrPC on
spermatids could originate from the Sertoli cells. Studies of
PrPC in spermatozoa and in fluids along the ram genital tract
revealed that the epididymal fluid contained significant levels
of what appeared to be soluble, highly glycosylated forms of
the prion protein (Gatti et al., 2002). The authors proposed
that some of PrPC species present on ejaculated spermatozoa
could be acquired from the seminal fluid during ejaculation.
While our investigations have not focused on seminal plasma
or epididymal fluids, IHC and IF analysis of the epididymis
showed that PrPC is present in cells below the columnar
epithelium, which itself appeared negative. However, the inter-
tubular connective tissue was strongly positive for PrPC, whereas
the smooth muscle stained substantially weaker for PrPC.
Although, these observations do not rule out secretion of
PrPC from the epididymal epithelium, it clearly illustrates that
PrPC appears to serve functions in the epididymis that are
unrelated to production and release of PrPC into the seminal
fluid.
Analyses of acrosome intactness, viability, ATP levels and
motility after oxidative stress induction with CuCl2 showed
no differences between the genotypes in their ability to handle
this stressor. The dramatic reduction in parameters are in
line with other studies on oxidative stress in spermatozoa
(Koppers et al., 2008). Our finding differ from results reported
by Shaked et al. (1999); namely that Cu2+ exposure caused
motility loss at a faster rate in spermatozoa from Prnp KO
mice. This apparent discrepancy could be due to different
experimental procedures or represent true species differences.
For instance, Shaked et al. studied spermatozoa extracted from
the epididymis, whereas we studied ejaculated spermatozoa that
have undergone routine dilutions and freezing in liquid nitrogen.
Epididymal mouse spermatozoa are immobile, but motility can
be established by dilution in specific buffers (Tash and Bracho,
1998). In our preparations of spermatozoa that had undergone
cryopreservation, approximately 30–40% of the spermatozoa
were recorded as motile. We observed, as expected, a gradual
decline in ATP levels and motility in untreated controls for both
genotype groups during the 60min incubation. From a breeder’s
point of view, it can be concluded that all fundamental
spermatozoa parameters as recorded in cryopreserved
semen, appear unaffected by the loss of PrPC in the goat
buck.
In order to explore further in vitro stress resilience, we
analyzed accumulations of ROS in spermatozoa from PRNP+/+
and PRNPTer/Ter bucks. Interestingly, we observed that a larger
proportion of viable spermatozoa from PRNP+/+ bucks fell into
the “high ROS” category (bright), demonstrating that under these
experimental conditions, higher numbers of PrPC-containing
spermatozoa contained higher ROS levels, while still remaining
viable. This surprising observation indicates that in mature
spermatozoa, PrPC appears not to contribute to ROS scavenging
capacity. This is in contrast to previous observations of increased
levels of ROS in various diploid PrPC-deficient cell lines (Choi
et al., 2007; Aude-Garcia et al., 2011; Bertuchi et al., 2012; Zanetti
et al., 2014).
We wanted to test whether our observation of complete lack
of PrPC-mediated stress protection could be a peculiarity of
spermatozoa prepared for AI. In order to achieve this, we exposed
goat PBMCs with and without PrPC and human neuroblastoma
SH-SY5Y cells expressing different levels of PrPC to different
types of genotoxic and oxidative stress. Interestingly, upon
exposure of cells to doxorubicin, an inducer of DNA double
strand breaks, H2O2 for induction of ROS stress, and MMS
for introduction of methyl adducts, we were unable to detect
any stress-protective effect of PrPC in terms of cellular viability
in any of the cell types. Contrary, we observed a statistically
significant increase in relative viability of PBMCs derived from
PRNPTer/Ter animals after H2O2 and MMS treatment, compared
with PBMCs from PRNP+/+ animals. The biological significance
or molecular explanation of this surprising observation remain
to be clarified. There was no effect of PrPC on levels of
7-m(dG), neither before nor after treatment with MMS. Our
data appear to be in line with the conclusion drawn by Castle
and Gill (Castle and Gill, 2017), in their recent review, that
a direct stress-protective function for PrPC remains unproven.
In accordance with previous observations, the SH-SY5Y cells
increased their expression of endogenous PrPC in response to
severe stress (Bravard et al., 2015). This effect was less consistent
in PBMCs, although a clear induction was evident after treatment
with doxorubicin. Our data do not provide support for the
concept that PrPC is critically important for DNA repair, as
reported by Bravard et al. (2015). They observed decreased
survival of SH-SY5Y cells without PrPC after treatment with
MMS and that DNA lesions were increased in the absence
of PrPC. Further investigations are needed to clarify this
issue.
Taken together, our data, derived from different cell types
and under a variety of stressful conditions, show that in vitro
there appears to be no stress-protective effects of PrPC. The
findings are in contrast to studies that have shown that PrPC
can positively influence survival of cells exposed to xanthine
oxidase (Brown et al., 1997, 2002), H2O2 (White et al., 1999;
Oh et al., 2012), and paraquat (Senator et al., 2004; Dupiereux
et al., 2008). It has been suggested that antioxidant enzyme
activities such as glutathione reductase (White et al., 1999)
or SOD-1 (Brown et al., 1997) are reduced in the absence of
PrPC. Other studies have not found changes in the enzyme
activities of glutathione peroxidase, catalase, and Cu/Zn SOD
(Brown et al., 2002). It has also been proposed that PrPC
stimulates the expression of antioxidant enzymes (White et al.,
1999; Klamt et al., 2001) and that this could partly explain
the protective effect of PrPC against oxidative stress. However,
RNA sequencing data from PBMCs derived from goats with
or without PrPC do not support this notion, since we were
unable to detect any differences between genotypes in expression
of major DNA repair enzymes or a panel of enzymatic
antioxidants.
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Interestingly, increased levels of oxidative DNA damage have
been detected in cells without PrPC during normal physiological
states (Watt et al., 2007). Higher levels of oxidated lipids and
proteins were reported in the CNS (Wong et al., 2001; bio Klamt
et al., 2001) and peripheral structures (bio Klamt et al., 2001) of
Prnp KOmice, reflecting a higher oxidative load. These scenarios
are likely to have yielded higher levels of enzymes involved in
these repair processes (Vogel and Marcotte, 2012); however, we
were unable to detect any major differences in neither DNA
damage-repair enzymes nor enzymatic antioxidants in PBMCs
from PRNP+/+ and PRNPTer/Ter animals.
In conclusion, our observations of PBMCs, spermatozoa and
SH-SY5Y cells after induction of different forms of severe cellular
stress suggest that PrPC is not directly protective against these
stressors in vitro. This, however, does not rule out that PrPC
could serve protective functions in vivo, particularly during
inflammation, as suggested in several studies in mice (McLennan
et al., 2004; Martin et al., 2011; Gourdain et al., 2012; Ezpeleta
et al., 2017), and goats (Salvesen et al., 2016, 2017).
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